1. bookVolumen 70 (2020): Edición 4 (December 2020)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as possible anticancer agents

Publicado en línea: 13 May 2020
Volumen & Edición: Volumen 70 (2020) - Edición 4 (December 2020)
Páginas: 499 - 513
Aceptado: 19 Nov 2019
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. S. H. Giordano, D. S. Cohen, A. U. Buzdar, G. Perkins and G. N. Hortobagyi, Breast carcinoma in men: a population-based study, Cancer: Interdisc. Int. J. Am. Cancer Soc.101 (2004) 51–57; https://doi.org/10.1002/cncr.2031210.1002/cncr.2031215221988Search in Google Scholar

2. L. W. C. Chow, A. Yun-San Yip, W. T. Y. Loo and M. Toi, Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer, Cancer Lett. 262 (2008) 232–238; https://doi.org/10.1016/j.canlet.2007.12.00310.1016/j.canlet.2007.12.00318248884Search in Google Scholar

3. A. M. Farag, A. S. Mayhoub, T. M. Eldebss, A. G. E. Amr, K. A. Ali, N. A. Abdel-Hafez and M. M. Abdulla, Synthesis and structure-activity relationship studies of pyrazole-based heterocycles as antitumor agents, Arch. Pharm. 343 (2010) 384–396; https://doi.org/10.1002/ardp.20090017610.1002/ardp.20090017620397210Search in Google Scholar

4. Z. Sahin, M. Ertas, B. Berk, S.N. Biltekin, L. Yurttas and S. Demirayak, Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl) thiazole derivatives, Bioorg. Med. Chem.26 (2018) 1986–1995; https://doi.org/10.1016/j.bmc.2018.02.04810.1016/j.bmc.2018.02.04829525337Search in Google Scholar

5. R. J. Santen, E. Samojlik, A. Lipton, H. Harvey, E. B. Ruby, S. A. Wells and J. Kendall, Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer, Cancer39 (1977) 2948–2958; https://doi.org/10.1002/1097-0142(197706)39:6<2948::AID-CNCR2820390681 >3.0.CO;2-9Search in Google Scholar

6. R. J. Santen, S. Santner, B. Davis, J. Veldhuis, E. Samojlik and E. Ruby, Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma, J. Clin. Endocrinol. Metab.47 (1978) 1257–1265; https://doi.org/10.1210/jcem-47-6-125710.1210/jcem-47-6-1257263348Search in Google Scholar

7. M. Ertas, Z. Sahin, B. Berk, L. Yurttas, S.N. Biltekin and S. Demirayak, Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation, Arch. Pharm.351 (2018) 1700272; https://doi.org/10.1002/ardp.20170027210.1002/ardp.20170027229522642Search in Google Scholar

8. P. Furet, C. Batzl, A. Bhatnagar, E. Francotte, G. Rihs and M. Lang, Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds, J. Med. Chem.36 (1993) 1393–1400.Search in Google Scholar

9. C. D. Jones, M. A. Winter, K. S. Hirsch, N. Stamm, H. M. Taylor, H. E. Holden, J. D. Davenport, E. V. Krumkalns and R. G. Suhr, Estrogen synthetase inhibitors. 2. Comparison of the in vitro aromatase inhibitory activity for a variety of nitrogen heterocycles substituted with diarylmethane or diarylmethanol groups, J. Med. Chem.33 (1990) 416–429.10.1021/jm00163a0652296032Search in Google Scholar

10. A. Cavalli and M. Recanatini, Looking for selectivity among cytochrome P450s inhibitors, J. Med. Chem. 45 (2002) 251–254; https://doi.org/10.1021/jm015567k10.1021/jm015567k11784128Search in Google Scholar

11. M. L. Fascio, C. S. Sepúlveda, E. B. Damonte and N. B. D’Accorso, Synthesis and antiviral activity of some imidazo [1,2-b][1,3,4] thiadiazole carbohydrate derivatives, Carbohydr. Res.480 (2019) 61–66; https://doi.org/10.1016/j.carres.2019.05.00310.1016/j.carres.2019.05.00331176191Search in Google Scholar

12. J. Chen, C. Yi, S. Wang, S. Wu, S. Li, D. Hu and B. Song, Novel amide derivatives containing 1,3,4-thiadiazole moiety: Design, synthesis, nematocidal and antibacterial activities, Bioorg. Med. Chem. Lett. 29 (2019) 1203–12010; https://doi.org/10.1016/j.bmcl.2019.03.01710.1016/j.bmcl.2019.03.01730902458Search in Google Scholar

13. G. Serban, Future prospects in the treatment of parasitic diseases: 2-Amino-1,3,4-thiadiazoles in leishmaniasis, Molecules24 (2019) 1557–1579; https://doi.org/10.3390/molecules2408155710.3390/molecules24081557651467331010226Search in Google Scholar

14. D. C. Sekhar, D. V. Rao, A. T. Rao, U. L. Kumar and A. Jha, Design and synthesis of 1,3,4-thiadiazole derivatives as novel anticancer and antitubercular agents, Russ. J. Gen. Chem.89 (2019) 770–779; https://doi.org/10.1134/S107036321904022410.1134/S1070363219040224Search in Google Scholar

15. A. Foroumadi, Z. Kargar, A. Sakhteman, Z. Sharifzadeh, R. Feyzmohammadi, M. Kazemi and A. Shafiee, Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3,4-thiadiazol-2-ylthio] propionates, Bioorg. Med. Chem. Lett.16 (2006) 1164–1167; https://doi.org/10.1016/j.bmcl.2005.11.08710.1016/j.bmcl.2005.11.08716359863Search in Google Scholar

16. B. Sharma, A. Verma, S. Prajapati and U. K. Sharma, Synthetic methods, chemistry, and the anticonvulsant activity of thiadiazoles, Int. J. Med. Chem.2013 (2013) Article ID 348948 (16 pages); https://doi.org/10.1155/2013/34894810.1155/2013/348948420745625405032Search in Google Scholar

17. V. Mathew, J. Keshavayya, V. P. Vaidya and D. Giles, Studies on synthesis and pharmacological activities of 3, 6-disubstituted-1,2,4-triazolo [3,4-b]-1,3,4-thiadiazoles and their dihydro analogues, Eur. J. Med. Chem.42 (2007) 823–840; https://doi.org/10.1016/j.ejmech.2006.12.01010.1016/j.ejmech.2006.12.01017331622Search in Google Scholar

18. İ. Celik, G. Ayhan-Kılcıgil, B. Guven, Z. Kara, A. S. Gurkan-Alp, A. Karayel and A. Onay-Besikci, Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors, Eur. J. Med. Chem.173 (2019) 240–249; https://doi.org/10.1016/j.ejmech.2019.04.01210.1016/j.ejmech.2019.04.01231009910Search in Google Scholar

19. M. F. Abo-Ashour, W. M. Eldehna, A. Nocentini, H. S. Ibrahim, S. Bua, H. A. Abdel-Aziz, S. M. Abou-Seri and C. T. Supuran, Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies, Bioorg. Chem.87 (2019) 794–802; https://doi.org/10.1016/j.bioorg.2019.04.00210.1016/j.bioorg.2019.04.00230978604Search in Google Scholar

20. D. I. Pérez, M. Pistolozzi, V. Palomo, M. Redondo, C. Fortugno, C. Gil, G. Felix, A. Martinez and C. Bertucci, 5-Imino-1,2,4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: determination of blood–brain barrier penetration and binding to human serum albumin, Eur. J. Pharm. Sci.45 (2012) 677–684; https://doi.org/10.1016/j.ejps.2012.01.00710.1016/j.ejps.2012.01.00722306656Search in Google Scholar

21. Y. Bahmani, T. Bahrami and A. Alabadi, Synthesis, cytotoxicity assessment and molecular docking of n-(5-(substituted-benzylthio)-1,3,4-thiadiazole-2-yl)-2-p-fluorophenylacetamide derivatives as tyrosine kinase inhibitors, Indian J. Pharm. Sci. 81 (2019) 63–70.10.4172/pharmaceutical-sciences.1000480Search in Google Scholar

22. A. S. Mayhoub, L. Marler, T. P. Kondratyuk, E. J. Park, J. M. Pezzuto and M. Cushman, Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets, Bioorg. Med. Chem.20 (2012) 510–520; https://doi.org/10.1016/j.bmc.2011.09.03110.1016/j.bmc.2011.09.031324895822115839Search in Google Scholar

23. M. Varache-Lembege, S. Moreau, S. Larrouture, D. Montaudon, J. Robert and A. Nuhrich, Synthesis and antiproliferative activity of aryl- and heteroaryl-hydrazones derived from xanthone carbaldehydes, Eur. J. Med. Chem.43 (2008) 1336–1343; https://doi.org/10.1016/j.ejmech.2007.09.00310.1016/j.ejmech.2007.09.003Search in Google Scholar

24. M. V. Berridge, P. M. Herst and A. S. Tan, Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction, Biotechnol. Annu. Rev.11 (2005) 127–152; https://doi.org/10.1016/S1387-2656(05)11004-710.1016/S1387-2656(05)11004-7Search in Google Scholar

25. Ü. Demir Özkay, Ö. D. Can, B. N. Sağlık, U. Acar Çevik, S. Levent, Y. Özkay, S. Ilgın and Ö. Atlı, Design, synthesis, and AChE inhibitory activity of new benzothiazole–piperazines, Bioorg. Med. Chem. Lett.26 (2016) 5387–5394; https://doi.org/10.1016/j.bmcl.2016.10.04110.1016/j.bmcl.2016.10.04127789142Search in Google Scholar

26. M. R. Haider, K. Ahmad, N. Siddiqui, Z. Ali, M. J. Akhtar, N. Fuloria, S. Fuloria, M. Ravichandran and M. S. Yar, Novel 9-(2-(1-arylethylidene)hydrazinyl)acridine derivatives: Target topoisomerase 1 and growth inhibition of HeLa cancer cells, Bioorg. Chem. 88 (2019) Article ID 102962; https://doi.org/10.1016/j.bioorg.2019.10296210.1016/j.bioorg.2019.10296231085373Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo